TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search results
Raising National Health Insurance (JKN) premiums may be necessary to ensure the sustainability of the program, but the government should refrain from making a dramatic increase like it did in 2020, an observer has warned.
The state-owned Health Care and Social Security Agency (BPJS Kesehatan) is planning to use a facial recognition technology to identify millions of its policyholders and to prevent fraud in the National Health Insurance (JKN) system.
The "expensive medicine" trope has again resurfaced in headlines across the country, when the fact of the matter is that Indonesians have many, many options when it comes to buying medicines, from branded imports to locally produced generic drugs.
The government acknowledges that the new single-class inpatient system for the National Health Insurance (JKN) program may reduce the number of the country's hospital beds by more than 23,000, but gave an assurance that it will not disrupt treatment or hospital admission for patients.
The Indonesian Ombudsman has called on the government to ensure better hospital facilities and fair premiums once standardized inpatient care for National Health Insurance (JKN) policyholders goes into full effect next year.
The implementation of KRIS is expected to improve the quality of service for JKN patients, especially existing class 3 patients. However, this policy also raises several issues for future practice.
The Healthcare and Social Security Agency (BPJS Kesehatan) has said a recent regulation on standardized inpatient care for National Health Insurance (JKN) policyholders will not affect premiums for at least a year.
